Estimates Revisions Alector, Inc.

Stocks

Market Closed - Nasdaq 06:00:00 23/09/26 am AEST			5-day change	1st Jan Change
2.010 ^USD	+4.15%		-1.23%	+28.85%

17/09	Novartis halts ALS drug development after mid-stage trial failure	RE
15/09	Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ALECTOR, INC.
	WUXI APPTEC CO., LTD.
	ARGENX SE
	WUXI BIOLOGICS (CAYMAN) INC.
	INSMED INCORPORATED
	BIONTECH SE
	GENMAB A/S
	PHARMAESSENTIA CORPORATION
	EXELIXIS, INC.
	SUMMIT THERAPEUTICS INC.
	Average
	Weighted average by Cap.